Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.

<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...

Повний опис

Бібліографічні деталі
Автори:	Onakpoya, I, Heneghan, C, Aronson, J
Формат:	Journal article
Мова:	English
Опубліковано:	BioMed Central 2016

Схожі ресурси

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
за авторством: Onakpoya, I, та інші
Опубліковано: (2017)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
за авторством: Onakpoya, IJ, та інші
Опубліковано: (2016)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
за авторством: Onakpoya, I, та інші
Опубліковано: (2016)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
за авторством: Igho J. Onakpoya, та інші
Опубліковано: (2019-03-01)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
за авторством: Onakpoya, I, та інші
Опубліковано: (2017)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
за авторством: Onakpoya, I
Опубліковано: (2017)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
за авторством: Onakpoya, I, та інші
Опубліковано: (2017)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
за авторством: Daniele Sartori, та інші
Опубліковано: (2020-08-01)

Pharmacogenetics and adverse drug reactions
за авторством: Ferner, R, та інші
Опубліковано: (2010)

An agenda for research on adverse drug reactions.
за авторством: Aronson, J
Опубліковано: (2007)

Adverse drug reactions--no farewell to harms.
за авторством: Aronson, J
Опубліковано: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
за авторством: Aronson, J
Опубліковано: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
за авторством: Edwards, I, та інші
Опубліковано: (2000)

Post-marketing drug withdrawals: pharmacovigilance success, regulatory problems : Arrêts de commercialisation de médicaments post-autorisation : succès de la pharmacovigilance, problèmes réglementaires
за авторством: Aronson, J
Опубліковано: (2017)

Adverse drug reactions: keeping up to date.
за авторством: Aronson, J, та інші
Опубліковано: (2002)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
за авторством: Aronson, J
Опубліковано: (2013)

Paradoxical reactions: Under-recognized adverse effects of drugs?
за авторством: Hauben, M, та інші
Опубліковано: (2006)

National differences in publishing papers on adverse drug reactions.
за авторством: Ferner, R, та інші
Опубліковано: (2005)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
за авторством: Onakpoya, IJ, та інші
Опубліковано: (2020)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
за авторством: Aronson, Jeffrey K.
Опубліковано: (2006)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
за авторством: Onakpoya, I, та інші
Опубліковано: (2018)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
за авторством: Aronson, J
Опубліковано: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
за авторством: Talbot, J, та інші
Опубліковано: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
за авторством: Talbot, J, та інші
Опубліковано: (2012)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
за авторством: Łukasz Dobrek
Опубліковано: (2022-08-01)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs
за авторством: James D. Noyes, та інші
Опубліковано: (2021-08-01)

Joining the DoTS: new approach to classifying adverse drug reactions.
за авторством: Aronson, J, та інші
Опубліковано: (2003)

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
за авторством: Smith, C, та інші
Опубліковано: (1996)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
за авторством: Aronson, J
Опубліковано: (2005)

Lorcaserin in obesity: minimal benefits and ill-defined harms
за авторством: Onakpoya, I, та інші
Опубліковано: (2019)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
за авторством: Loke, Y, та інші
Опубліковано: (2006)

Pharmacogenomics of cutaneous adverse drug reactions as implication for precision medicine
за авторством: Chun-Bing Chen
Опубліковано: (2023-01-01)

Individualized medicine: Sex, hormones, genetics, and adverse drug reactions
за авторством: Ann M. Moyer, та інші
Опубліковано: (2019-12-01)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
за авторством: Aronson, J, та інші
Опубліковано: (2010)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
за авторством: Talbot, J. C. C., та інші
Опубліковано: (2012)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
за авторством: McDowell, SE, та інші
Опубліковано: (2013)

GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
за авторством: Ziqi Zhang, та інші
Опубліковано: (2023-07-01)

Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
за авторством: Ruoqi Liu, та інші
Опубліковано: (2019-12-01)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
за авторством: Derry, S, та інші
Опубліковано: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
за авторством: Derry, S, та інші
Опубліковано: (2001)